PPT-Seasonal Malaria Chemoprevention: WHO Policy and Perspectives

Implementation Workshop on Seasonal Malaria Chemoprevention 1315 February 2017 Ouagadougou Burkina Faso Dr Peter OLUMESE Global Malaria Programme WHO Geneva Switzerland MDG 6 target to halt amp reverse the incidence of malaria. However WHO estimates that as of 1997 at least onethird of the world57557s population still lacks access to essential medicines either because these are not available or are too expensive or because there are no adequate facilities or trained profes P. knowlesi malaria is primarily a public health problem among populations living or working in forested areas in south-east Asia. In recent years, sporadic cases of travellers 1 WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC)for Plasmodium falciparummalaria control in highly seasonal transmission areas of the Sahel subregion in AfricaMarch 2012 Background 2013 - 2 - - 3 - 1 3 ) Preamble Malaria is one of the major public health problems of the country. Around 1.5 million laboratory confirmed cases of malaria are annually reported in India . Intro. Introductions. Value. Perspectives. Challenges. Discussion. Lead Into . Gold. : . The Alchemy of Open Data. . . August 2, 2010. TASSCC Annual Conference. Agenda. Janet Gilmore. 1. 2. Janet Gilmore. 2 – 4 October 2019, Geneva, Switzerland Background document for Session 3 This document was prepared as a pre - read for the meeting of the Malaria Policy Advisory Committee and is not an official d Min of H & FW, GOI. Dr. Pradeep Kumar, . MD, FIAPSM,. Professor & Head,. Community Medicine Dept.. GMERS Medical College, Sola, Ahmedabad. E mail: drpkumar_55@yahoo.com. 1. 2. Why now?. Introduction. The bigger picture: implications for the future of SM. C. 2. nd. March 2022. Taking SMC to new geographies. The research in Mozambique and Uganda explores if SMC with SPAQ can be a viable malaria prevention strategy in east and southern Africa, despite . (CPES). Charlotte Rasmussen. Pascal Ringwald. Guidelines for chemoprevention interventions are currently being reviewed. Use of chemoprevention is likely to be further expanded in coming years. In some countries there has a relatively low uptake of chemoprevention; one of the reasons sited is concerns over resistance and efficacy. Piloting Reveal for use in seasonal malaria chemoprevention in Nigeria . Seasonal malaria chemoprevention (SMC). Implementing the pilot (usability testing). The Reveal workflow in SMC . Preliminary coverage results and key findings. Implementation Workshop on Seasonal Malaria Chemoprevention. 13-15 February 2017,. Ouagadougou, Burkina Faso. Dr.. Peter OLUMESE, . Global Malaria Programme. WHO, Geneva, Switzerland.. DEFINITION OF ‘REBOUND’ IN RELATION TO MALARIA CONTROL. 3 March 2022. David Schellenberg. Science Adviser. The. . 3. . steps in the pathway. to achieve . impact. Better . . anticipate. products. . or. . strategies . . that . are . likely . to . be . Committee. WHO . Global Malaria Programme. Dr . Pedro L. Alonso, . Director. Malaria Policy Advisory Committee (MPAC). Convened in January 2012 and every 6 . mths. since. MPAC advises the WHO DG through GMP. Kenya Malaria Matchbox Assessment. Background . Assessment . identified . barriers to utilization of malaria interventions among key vulnerable and disadvantaged populations in Kenya.. Identifying barriers: sociocultural, financial, physical, or related to gender norms is an essential step to matching people's specific needs to person-.